vs
LIFECORE BIOMEDICAL, INC. \DE\（LFCR）与REDWOOD TRUST INC（RWT）财务数据对比。点击上方公司名可切换其他公司
LIFECORE BIOMEDICAL, INC. \DE\的季度营收约是REDWOOD TRUST INC的1.2倍（$31.1M vs $25.9M），REDWOOD TRUST INC净利率更高（77.2% vs -32.1%，领先109.3%），LIFECORE BIOMEDICAL, INC. \DE\同比增速更快（-4.5% vs -6.1%），过去两年LIFECORE BIOMEDICAL, INC. \DE\的营收复合增速更高（-0.1% vs -41.0%）
LIFECORE BIOMEDICAL, INC.是一家生物医药企业，专注于研发和生产以透明质酸为主的高品质生物材料，业务覆盖医疗应用产品、制药解决方案、个人护理原料三大核心板块，主要市场遍布北美、欧洲、亚太地区，服务头部医疗器械、制药、美妆品牌客户。
Redwood Trust Inc是总部位于美国的专业房地产投资信托公司，主营住宅与商业抵押贷款、抵押贷款支持证券及房地产信贷类资产的投资管理，核心业务覆盖住宅抵押贷款发放、商业地产信贷和投资服务，客户以机构投资者和房地产市场参与者为主。
LFCR vs RWT — 直观对比
营收规模更大
LFCR
是对方的1.2倍
$25.9M
营收增速更快
LFCR
高出1.6%
-6.1%
净利率更高
RWT
高出109.3%
-32.1%
两年增速更快
LFCR
近两年复合增速
-41.0%
损益表 — Q2 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $31.1M | $25.9M |
| 净利润 | $-10.0M | $20.0M |
| 毛利率 | 25.0% | — |
| 营业利润率 | -9.9% | — |
| 净利率 | -32.1% | 77.2% |
| 营收同比 | -4.5% | -6.1% |
| 净利润同比 | -52.0% | 402.6% |
| 每股收益（稀释后） | $-0.29 | $0.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收LFCRRWT
| Q4 25 | — | $25.9M | ||
| Q3 25 | $31.1M | $15.0M | ||
| Q2 25 | — | $13.8M | ||
| Q1 25 | $35.2M | $27.9M | ||
| Q4 24 | $32.6M | $27.6M | ||
| Q3 24 | $24.7M | $25.5M | ||
| Q2 24 | — | $67.4M | ||
| Q1 24 | $35.7M | $74.5M |
净利润LFCRRWT
| Q4 25 | — | $20.0M | ||
| Q3 25 | $-10.0M | $-7.7M | ||
| Q2 25 | — | $-98.5M | ||
| Q1 25 | $-14.8M | $16.1M | ||
| Q4 24 | $-6.6M | $-6.6M | ||
| Q3 24 | $-16.2M | $14.8M | ||
| Q2 24 | — | $15.5M | ||
| Q1 24 | $15.6M | $30.3M |
毛利率LFCRRWT
| Q4 25 | — | — | ||
| Q3 25 | 25.0% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 28.0% | — | ||
| Q4 24 | 34.0% | — | ||
| Q3 24 | 21.8% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 33.3% | — |
营业利润率LFCRRWT
| Q4 25 | — | — | ||
| Q3 25 | -9.9% | -9.0% | ||
| Q2 25 | — | -679.0% | ||
| Q1 25 | -25.7% | 80.2% | ||
| Q4 24 | -6.0% | -1.3% | ||
| Q3 24 | -46.9% | 86.1% | ||
| Q2 24 | — | 30.3% | ||
| Q1 24 | -2.5% | 41.3% |
净利率LFCRRWT
| Q4 25 | — | 77.2% | ||
| Q3 25 | -32.1% | -51.4% | ||
| Q2 25 | — | -712.0% | ||
| Q1 25 | -42.0% | 57.8% | ||
| Q4 24 | -20.2% | -24.0% | ||
| Q3 24 | -65.7% | 58.1% | ||
| Q2 24 | — | 23.0% | ||
| Q1 24 | 43.8% | 40.6% |
每股收益（稀释后）LFCRRWT
| Q4 25 | — | $0.11 | ||
| Q3 25 | $-0.29 | $-0.08 | ||
| Q2 25 | — | $-0.76 | ||
| Q1 25 | $-0.47 | $0.10 | ||
| Q4 24 | $-0.25 | $-0.08 | ||
| Q3 24 | $-0.53 | $0.09 | ||
| Q2 24 | — | $0.10 | ||
| Q1 24 | $0.42 | $0.21 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $18.9M | $255.7M |
| 总债务越低越好 | $136.0M | — |
| 股东权益账面价值 | $-10.5M | $982.6M |
| 总资产 | $235.2M | $23.7B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
现金及短期投资LFCRRWT
| Q4 25 | — | $255.7M | ||
| Q3 25 | $18.9M | $226.3M | ||
| Q2 25 | — | $302.0M | ||
| Q1 25 | $5.4M | $259.9M | ||
| Q4 24 | $9.5M | $245.2M | ||
| Q3 24 | — | $253.7M | ||
| Q2 24 | — | $275.6M | ||
| Q1 24 | — | $275.4M |
总债务LFCRRWT
| Q4 25 | — | — | ||
| Q3 25 | $136.0M | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $124.9M | — | ||
| Q4 24 | $111.3M | — | ||
| Q3 24 | $106.3M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $97.1M | $1.7B |
股东权益LFCRRWT
| Q4 25 | — | $982.6M | ||
| Q3 25 | $-10.5M | $999.0M | ||
| Q2 25 | — | $1.1B | ||
| Q1 25 | $2.2M | $1.2B | ||
| Q4 24 | $15.4M | $1.2B | ||
| Q3 24 | $-3.9M | $1.2B | ||
| Q2 24 | — | $1.2B | ||
| Q1 24 | $17.7M | $1.2B |
总资产LFCRRWT
| Q4 25 | — | $23.7B | ||
| Q3 25 | $235.2M | $22.6B | ||
| Q2 25 | — | $21.3B | ||
| Q1 25 | $237.7M | $19.9B | ||
| Q4 24 | $255.4M | $18.3B | ||
| Q3 24 | $246.8M | $18.4B | ||
| Q2 24 | — | $16.5B | ||
| Q1 24 | $246.2M | $15.1B |
负债/权益比LFCRRWT
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 56.05× | — | ||
| Q4 24 | 7.20× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 5.49× | 1.39× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $1.8M | $-10.1B |
| 自由现金流经营现金流 - 资本支出 | $25.0K | — |
| 自由现金流率自由现金流/营收 | 0.1% | — |
| 资本支出强度资本支出/营收 | 5.6% | — |
| 现金转化率经营现金流/净利润 | — | -504.15× |
| 过去12个月自由现金流最近4个季度 | $-16.8M | — |
8季度趋势，按日历期对齐
经营现金流LFCRRWT
| Q4 25 | — | $-10.1B | ||
| Q3 25 | $1.8M | $-2.7B | ||
| Q2 25 | — | $-2.1B | ||
| Q1 25 | $1.2M | $-2.0B | ||
| Q4 24 | $-6.1M | $-5.9B | ||
| Q3 24 | $-613.0K | $-2.1B | ||
| Q2 24 | — | $-2.0B | ||
| Q1 24 | $-1.4M | $-954.2M |
自由现金流LFCRRWT
| Q4 25 | — | — | ||
| Q3 25 | $25.0K | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $-4.3M | — | ||
| Q4 24 | $-8.6M | — | ||
| Q3 24 | $-4.0M | — | ||
| Q2 24 | — | — | ||
| Q1 24 | $-7.8M | — |
自由现金流率LFCRRWT
| Q4 25 | — | — | ||
| Q3 25 | 0.1% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | -12.1% | — | ||
| Q4 24 | -26.3% | — | ||
| Q3 24 | -16.3% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | -21.8% | — |
资本支出强度LFCRRWT
| Q4 25 | — | — | ||
| Q3 25 | 5.6% | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 15.5% | — | ||
| Q4 24 | 7.5% | — | ||
| Q3 24 | 13.9% | — | ||
| Q2 24 | — | — | ||
| Q1 24 | 17.8% | — |
现金转化率LFCRRWT
| Q4 25 | — | -504.15× | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -120.92× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -140.86× | ||
| Q2 24 | — | -126.56× | ||
| Q1 24 | -0.09× | -31.53× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LFCR
| Transferred At Point In Time | $26.6M | 85% |
| Transferred Over Time | $4.5M | 15% |
RWT
暂无分部数据
